ATTUNE - ABATACEPT IN SUBJECTS WHO SWITCH FROM INTRAVENOUS TO SUBCUTANEOUS THERAPY Trademark

Trademark Overview

On Friday, October 29, 2010, a trademark application was filed for ATTUNE - ABATACEPT IN SUBJECTS WHO SWITCH FROM INTRAVENOUS TO SUBCUTANEOUS THERAPY with the United States Patent and Trademark Office. The USPTO has given the ATTUNE - ABATACEPT IN SUBJECTS WHO SWITCH FROM INTRAVENOUS TO SUBCUTANEOUS THERAPY trademark a serial number of 85164770. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 20, 2014. This trademark is owned by Bristol-Myers Squibb Company. The ATTUNE - ABATACEPT IN SUBJECTS WHO SWITCH FROM INTRAVENOUS TO SUBCUTANEOUS THERAPY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use
attune - abatacept in subjects who switch from intravenous to subcutaneous therapy

General Information

Serial Number85164770
Word MarkATTUNE - ABATACEPT IN SUBJECTS WHO SWITCH FROM INTRAVENOUS TO SUBCUTANEOUS THERAPY
Filing DateFriday, October 29, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 20, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2011

Trademark Statements

Disclaimer with Predetermined Text"ABATACEPT IN SUBJECTS WHO SWITCH FROM INTRAVENOUS TO SUBCUTANEOUS THERAPY"
Goods and ServicesMedical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 3, 2010
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Tuesday, January 21, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 20, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 18, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, June 16, 2013EXTENSION 4 GRANTED
Friday, June 14, 2013EXTENSION 4 FILED
Friday, June 14, 2013TEAS EXTENSION RECEIVED
Tuesday, March 12, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 20, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, November 19, 2012EXTENSION 3 GRANTED
Friday, November 16, 2012EXTENSION 3 FILED
Friday, November 16, 2012TEAS EXTENSION RECEIVED
Tuesday, June 5, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, June 4, 2012EXTENSION 2 GRANTED
Wednesday, May 9, 2012EXTENSION 2 FILED
Friday, June 1, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 9, 2012TEAS EXTENSION RECEIVED
Thursday, November 3, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, November 1, 2011EXTENSION 1 GRANTED
Tuesday, November 1, 2011EXTENSION 1 FILED
Tuesday, November 1, 2011TEAS EXTENSION RECEIVED
Tuesday, June 14, 2011NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 19, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 19, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 19, 2011PUBLISHED FOR OPPOSITION
Wednesday, March 30, 2011NOTICE OF PUBLICATION
Friday, March 11, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 11, 2011ASSIGNED TO LIE
Wednesday, February 16, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 16, 2011EXAMINER'S AMENDMENT MAILED
Tuesday, February 15, 2011EXAMINER'S AMENDMENT ENTERED
Tuesday, February 15, 2011EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 8, 2011ASSIGNED TO EXAMINER
Wednesday, November 3, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 2, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

intravenous subcutaneous therapy from switch abatacept subjects attune clinical relating pharmaceutical preparations human studies trials research namely conducting